PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 176 filers reported holding PRECIGEN INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,816 | +141.1% | 32,969 | +80.0% | 0.00% | – |
| Q1 2023 | $19,418 | -93.7% | 18,319 | -92.0% | 0.00% | – |
| Q2 2022 | $307,000 | +149.6% | 229,441 | +294.0% | 0.00% | – |
| Q1 2022 | $123,000 | -69.7% | 58,232 | -46.7% | 0.00% | – |
| Q4 2021 | $406,000 | -21.5% | 109,272 | +5.4% | 0.00% | – |
| Q3 2021 | $517,000 | -30.1% | 103,683 | -8.6% | 0.00% | – |
| Q2 2021 | $740,000 | -13.5% | 113,400 | -8.7% | 0.00% | – |
| Q1 2021 | $855,000 | -27.7% | 124,200 | +7.1% | 0.00% | – |
| Q4 2020 | $1,183,000 | +276.8% | 115,972 | +29.3% | 0.00% | – |
| Q3 2020 | $314,000 | -9.5% | 89,679 | +29.0% | 0.00% | – |
| Q2 2020 | $347,000 | +417.9% | 69,525 | +254.0% | 0.00% | – |
| Q1 2020 | $67,000 | – | 19,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |